PTP1B inhibitors (DARA)

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug NamePTP1B inhibitors (DARA)

Drug Alias Nameprotein tyrosine phosphatase inhibitors (DARA)protein tyrosine phosphatase inhibitors (OnsetThera)PTP1B inhibitors (OnsetThera)OTX-001OTX-002

ClassificationSmall molecules

Mechanisms of ActionInsulin sensitizersProtein-tyrosine phosphatase 1B inhibitorsImmunomodulators +[4]

TargetsProtein-tyrosine phosphatase 1B

Therapy Area/IndicationsInflammationImmune System DiseasesObesity +[5]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAlbert Einstein College Of Medicine Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesFortovia Therapeutics Inc Albert Einstein College Of Medicine Inc

Active IndicationsN/A

Inactive IndicationsInflammationImmune System DiseasesObesity +[5]

Other Information

ATC CodeN/A